Imbria Pharmaceuticals, Inc. — Form D
Imbria Pharmaceuticals, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-09. The offering totals $40.2M, of which $40.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-07-09
- Form: D
- Accession: 0001745672-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $40.2M
- Amount sold: $40.2M
- Investors: 3
- Date of first sale: 2018-07-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-316241
Issuer
- Name: Imbria Pharmaceuticals, Inc.
- CIK: 0001745672
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 265 FRANKLIN STREET, BOSTON, MA, 02110
- Phone: 917-657-5069
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Pieter C Boelhouwer | Director | Rancho Santa Fe, CA |
| David-Alexandre C Gros | Director | Boston, MA |
| Pavan Cheruvu | Director | Boston, MA |
| Charles Dunn | Director | Boston, MA |
| Alvin Shih | Director | Boston, MA |
| Alvin Shih | Executive Officer | Boston, MA |
| Luse Rebecca | Director | Boston, MA |
| Ken Horne | Director | Boston, MA |
| Komal Joshi | Executive Officer | Boston, MA |
| Andrew Levin | Director | BOSTON, MA |
| Zina Affas Besse | Director | WOODLAND HILLS, CA |
| Rebecca Luse | Director | Boston, MA |
| James Januzzi | Director | Boston, MA |
| Andrew C Levin | Director | Boston, MA |
| David-Alexandre C Gros | Executive Officer | Boston, MA |
| James C Januzzi | Director | Boston, MA |
Other filings by this issuer (3)
More